Jan 02 2025 25 mins
Join us for our second discussion with Professor Alison Birtle on metastatic prostate cancer.
This time we look at mCRPC. What are our choices after first line therapy.
We discuss;
-PARPi and BRCA testing
-Docetaxel re-challenge
-Cabazitaxel
-Patient Support
This is a real tour de force by Alison.
We hope you enjoy.
John & Mike